Emergency treatment of complicated colorectal cancer by Tebala, Giovanni Domenico et al.
© 2018 Tebala et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. 
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work 
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For 
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Cancer Management and Research 2018:10 827–838
Cancer Management and Research Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
827
O R I G I N A L  R E S E A R C H
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/CMAR.S158335
Emergency treatment of complicated  
colorectal cancer
Giovanni Domenico Tebala1
Andrea Natili1,2
Antonio Gallucci1
Gioia Brachini2
Abdul Qayyum Khan1
Domenico Tebala3
Andrea Mingoli2
1Colorectal Team, Noble’s Hospital, 
Strang, Douglas, Isle of Man, UK; 
2Emergency Surgery Unit, “P.Valdoni” 
Department of Surgery, “Umberto 
I” University Hospital, Rome, Italy;  
3National Institute of Statistics 
(ISTAT), Catanzaro, Italy
Aim: To find evidence to suggest the best approach in patients admitted as an emergency for 
complicated colorectal cancer.
Methods: The medical records of 131 patients admitted as an emergency with an obstructing, 
perforated, or bleeding colorectal cancer to Noble’s Hospital, Isle of Man, and the Umberto I 
University Hospital, Rome, were retrospectively evaluated. Patients were divided in 3 groups on 
the basis of the emergency treatment they received, namely 1) immediate resection, 2) damage 
control procedure and elective or semielective resection, and 3) no radical treatment. Demo-
graphic variables, clinical data, and treatment data were considered, and formed the basis for 
the comparison of groups. Primary endpoints were 90-day mortality and morbidity. Secondary 
endpoints were length of stay, number of lymph nodes analyzed, rate of radical R0 resections, 
and the number of patients who had chemoradiotherapy.
Results: Forty-two patients did not have any radical treatment because the cancer was too 
advanced or they were too ill to tolerate an operation, 78 patients had immediate resection and 
11 had damage control followed by elective resection. There was no statistically significant dif-
ference between immediate resections and 2-stage treatment in 90-day mortality and morbidity 
(mortality: 15.4% vs 0%; morbidity: 26.9% vs 27.3%), number of nodes retrieved (16.6±9.4 
vs 14.9±5.7), and rate of R0 resections (84.6% vs 90.9%), but mortality was slightly higher in 
patients who underwent immediate resection. The patients who underwent staged treatment had 
a higher possibility of receiving a laparoscopic resection (11.5% vs 36.4%).
Conclusion: The present study failed to demonstrate a clear superiority of one treatment with 
respect to the other, even if there is an interesting trend favoring staged resection.
Keywords: colorectal cancer, colorectal surgery, obstructing colorectal cancer, perforated 
colorectal cancer, emergency surgery
Introduction
Colorectal cancer (CRC) is the third most frequent malignant disease worldwide, 
with an incidence of more than a million new cases per year.1 In the UK and in Italy, 
CRC incidence is about 70 new cases/100,000/yr.2,3 A significant proportion of these 
patients (14%–33%) present as an emergency with bowel obstruction, perforation, or 
bleeding.4,5 Unfortunately, these cancers are usually more aggressive and have a worse 
prognosis than those treated electively.6
Despite the many attempts at standardization, the best treatment for CRC pre-
senting as an emergency is still a matter for debate.7–9 Furthermore, different local 
arrangements make it difficult to find a homogeneous approach. In the UK, all cases 
of CRC must be managed by a Colorectal Multidisciplinary Team,10 where surgeons 
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must be specifically trained and experienced in colorectal 
surgery. While this is feasible in elective cases, a colorectal 
surgeon may not be immediately available if the patient 
presents out of hours. In these cases, the emergency must 
be managed by the on-call surgeon and the patient must be 
transferred to the relevant team/hospital as soon as possible. 
However, Italy does not yet have this level of subspecializa-
tion, and CRCs are usually managed by general surgeons, 
both as emergency or elective cases. The classic approach 
has been to treat the cancer and its complication in one go 
with a resection in emergency. A new approach has recently 
emerged, in particular in the UK, due to the above reported 
concerns regarding the specific qualification and training of 
the emergency surgeons, deriving its basic concepts from 
trauma surgery. The philosophy of “damage control,” initially 
proposed for trauma patients, has been extended to nontrauma 
conditions.11 In this approach, the surgical complication can 
be treated in the emergency setting with minimal and targeted 
procedures aimed at controlling the acute condition (obstruc-
tion, perforation, or bleeding) while the patient is stabilized, 
in order to delay the definitive treatment of the CRC until he 
or she can be transferred to the care of the specialized team.10
This retrospective study has been conducted to provide 
further evidence to support the choice of the best treatment 
for CRC, namely immediate resection vs elective resection.
Methods
The medical records of all consecutive patients with CRC 
admitted as emergency from March 2013 to January 2017 
under the care of the Colorectal Team of Noble’s Hospital, 
Isle of Man (British Isles), and the Emergency Surgery Unit 
of the Umberto I University Hospital, Rome (Italy), have 
been retrospectively analyzed. The Noble’s is a 314-bed 
teaching hospital serving about 90,000 citizens of the Isle 
of Man. The Isle of Man is located at the middle of the Irish 
Sea, about 60 miles from tertiary centers in mainland UK. 
The Colorectal Unit deals with about 80 new CRCs per year, 
both as elective and emergent cases. Umberto I is a 1,200-bed 
tertiary university hospital situated at the center of Rome; its 
Emergency Surgery Department is one of the busiest of the 
20 emergency departments (EDs) in the capital city.
The patients’ data regarding the treatment of their CRCs 
have been collected into an electronic database created with 
MS Excel for Mac v14.7.2 (Microsoft, Redmond, WA, USA), 
and each single variable was checked for typos and missing 
data. Variables with missing data >10% were discarded. 
Afterward, data were imported and analyzed with IBM SPSS 
for Mac v.20.0.0. Distribution of continuous variables was 
checked.
The variables considered in the study were demographics 
(gender, age), clinical data (time between symptoms onset 
and admission, time between admission and first treatment, 
American Society of Anesthesiologists (ASA) score, type of 
emergency presentation), and treatment data (which emer-
gency treatment, ostomy, laparoscopic vs open approach, 
eventual neoadjuvant or adjuvant treatment).
Primary endpoints were 90-day mortality and morbidity 
(Clavien >2).12 Secondary endpoints were length of stay, 
number of lymph nodes analyzed, rate of radical R0 resec-
tions, and the number of patients who had chemoradiotherapy.
The cancers have been staged with the usual systems 
(TNM and Dukes), but other parameters have also been con-
sidered, such as the number of positive nodes, lymph node 
ratio (positive nodes/total nodes), lymph-vascular infiltration, 
and the status of the circumferential resection margin.
Ordinal or nominal variables have been compared with 
Pearson’s χ2 test. Frequencies are presented as number of 
cases and percentage. Continuous variables have been com-
pared with the independent samples Student’s t-test if the 
variable had a normal (Gaussian) distribution or with the 
Mann–Whitney U-test if the variable was not distributed 
normally. These variables are presented as mean ± standard 
deviation and/or median and range.
The correlation between 2 or more continuous variables has 
been tested with linear regression analysis, whereas correlation 
between 2 or more nominal or ordinal variables has been tested 
with logistic regression analysis. Multiple logistic regression 
has been used to check for independent variables. All the 
analyzed variables have been considered in the multivariate 
analysis, irrespective of their significance at univariate analysis.
Values of p<0.05 (2-tailed test) have been considered 
significant, but borderline statistical significance has been 
discussed as well, as it may denote an important “trend” 
which did not reach statistical significance probably due to 
the size of the sample.
An initial evaluation has been done on the whole series, 
mostly to compare the data of the 2 participating units and 
establish if there was any difference due to national guidelines 
or local policies or attitude.
Subsequent elaboration has been carried out only on 
the series of patients who underwent radical treatment. Two 
groups have been compared: 1) patients who had emergency 
resection; and 2) patients treated with elective resection after 
initial stabilization and damage control procedure.
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The statistical methods of this study were reviewed by 
one of the authors (DT), who is a statistician at the Italian 
National Institute of Statistics.
The retrospective nature of this study made formal ethical 
approval unnecessary. However, the Ethical Committees of 
both the Noble’s Hospital and the Umberto I Hospital have 
been informed, and they both considered ethical approval and 
patient consent were not necessary on the following bases: 
1) data were completely anonymized, 2) data were collected 
as part of the normal treatment for those patients and were 
subsequently analyzed within an audit aimed at improving 
our quality of care, 3) patients were treated according to 
national and international guidelines (discussed below), 
and 4) no experimental or new treatments/protocols are 
included in this report. Written approval was obtained by 
the Audit Committee of the Noble’s Hospital. Patients’ data 
confidentiality was not breached as all data were collected 
and analyzed in an anonymized manner. All patients gave 
full informed consent to the treatment, either resection or 
nonoperative management.
This report has been written following the PROCESS 
guidelines.13
Results
A total of 131 medical records were examined, 71 from 
Noble’s Hospital and 60 from the Umberto I University 
Hospital. Due to local restrictions, follow-up data and other 
clinical variables (amount of fluids given, transfusions, 
medications) were not available.
Results are reported in Tables 1–7.
The 2 initial groups were matched for gender distribution, 
age, and type of presentation. Manx patients had a higher rate 
of metastatic cancers (41.4% vs 25.9%, p=0.065) (Table 1).
Forty-two patients (32.1%) did not have a radical treat-
ment. Thirteen out of these 42 patients had only medical 
palliative symptomatic treatment, whereas 29 underwent 
an invasive procedure. However, 5 patients had only an 
abdominal exploration (laparoscopic or open) with no active 
procedure. Twenty-four patients (57.1% of the nonresectable 
patients) had some form of diversion (Table 2).
The majority of patients (61.8%) had the first treatment 
within 24 hours from admission. This rate was higher in the 
Italian group (78.3% vs 47.9%, p=0.001).
Only 4 patients had colonic stenting as emergency treat-
ment, so this parameter was not evaluated further.
The majority of patients had their first treatment by 
open surgery, but more than one-quarter of Manx patients 
had an emergency laparoscopy as first treatment. Forty-two 
percent of patients had a stoma as initial treatment (or part 
of it) (Table 2).
Females and patients with a high ASA score were more 
likely to receive an emergency resection. Clearly, perforated 
cancers were preferably resected in emergency, even if some 
patients with perforated colon cancer did not have any radi-
cal treatment due to too advanced cancer or too poor general 
conditions. The majority of patients with left colon cancers 
underwent resection on emergency, while about one-third of 
patients with rectal cancers had a 2-step procedure. A sur-
prisingly high number of patients with right colon or rectal 
cancer did not have any radical treatment (Table 3).
Manx patients were more likely to receive neoadjuvant 
chemoradiotherapy or palliative chemotherapy. Young 
patients were more likely to receive chemo- or chemoradio-
therapy. While the rate of patients not receiving any form of 
chemoradiotherapy was similar with respect to anatomical 
location of the tumor, neoadjuvant chemoradiotherapy was 
performed only in rectal cancer patients, whereas adjuvant 
chemotherapy was more frequent in left colon cancers and 
palliative chemotherapy in right colon cancers. The patients 
who had 2-step treatment and those who had laparoscopic 
resection were more likely to receive chemo- and/or radio-
therapy (Tables 4 and 5).
Further analysis was performed on the group of 89 
patients who had radical treatment, that is 52 patients (86.7%) 
of the Italian group and 37 (52.1%) of the Manx group. 
Seventy-eight patients had immediate resection, whereas 11 
had damage control and subsequent elective resection. Imme-
diate resection was performed by laparoscopy in 11.5% of 
cases (9 patients), whereas delayed resection was completed 
by laparoscopy in 36.4% of cases (4 patients) (p=0.029). All 
patients were operated on by consultants. All patients with 
staged treatment were operated on by subspecialist colorectal 
surgeons after discussion at a colorectal multidisciplinary 
team meeting.
Table 6 reports the results of univariate analysis with 
respect to the study endpoints.
In multivariate analysis (Table 7), mortality and morbidity 
were significantly directly correlated to the ASA score and 
Dukes stage. Furthermore, the laparoscopic technique was 
an independent protective factor for morbidity. Longer stays 
were related to late admission and delayed first treatment. The 
only independent factor increasing the risk of having a stoma 
was distal location of the cancer. Chemo- and/or radiotherapy 
has been offered more frequently to young patients. The 
number of nodes analyzed was independently related to the 
ASA score and location of the cancer. The ASA score was 
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also independently related to the rate of adequate clearance, 
along with Dukes’ stage. Interestingly, also on multivariate 
analysis, infiltration of the surgical margin was more frequent 
in patients operated on by open surgery and in those with 
delayed emergency treatment at first admission.
Discussion
Although the elective approach to CRCs has already been 
defined and national guidelines and local protocols have been 
released and widely followed, the treatment of CRC present-
ing as emergency – obstruction, perforation, or significant 
bleeding – has yet to be standardized and often the choice is 
left with the on-duty/on-call surgeon. UK guidelines suggest 
that every CRC – elective or emergency – must be managed 
by a consultant colorectal surgeon who is a core member 
of a multidisciplinary team.10 Clearly, this may not be pos-
sible if the patient is admitted off-hours, when the colorectal 
surgeon may not be on-call. In this case, the patient should 
be transferred under the care of the relevant team as soon as 
possible.10 Nonetheless, it is not completely clear if treatable 
Table 1 Demographics and basic clinical data
 Total Umberto I University Hospital Noble’s Hospital p-value
Number of cases 131 60 (45.8%) 71 (54.2%)
Gender 0.495
M 70 (53.4%) 34 (56.7%) 36 (50.7%)
F 61 (46.6%) 26 (43.3%) 35 (49.3%)
Age (years)a 73.5±12.6
74 (35–97)
73.3±11.7
73.5 (43–94)
73.7±13.3
74 (35–97)
0.862
Presentation 0.480
Obstruction 108 (82.4%) 47 (78.3%) 61 (85.9%)
Perforation 15 (11.5%) 8 (13.3%) 7 (9.9%)
Bleeding 8 (6.1%) 5 (8.3%) 3 (4.2%)
Symptom onset to admission (days)a 19.3±61.6
2 (0–488)
19.9±57.8
4.5 (0–375)
18.7±65.1
1 (0–488)
0.003
Admission to first treatment (days)a 4.1±11.3
0 (0–99)
3.0±13.0
0 (0–99)
5.2±9.3
1 (0–37)
0.006
ASA 0.015
1 8 (6.1%) 0 8 (11.3%)
2 43 (32.8%) 18 (30.0%) 25 (35.2%)
3 55 (42.0%) 32 (53.3%) 23 (32.4%)
4 24 (18.3%) 9 (15.0%) 15 (21.1%)
5 1 (0.8%) 1 (1.7%) 0
T 0.395
2 2 (1.6%) 0 2 (2.9%)
3 59 (46.1%) 26 (44.8%) 33 (47.1%)
4 67 (52.3%) 32 (55.2%) 35 (50.0%)
(Missing) 3 2 1
N 0.343
0 50 (39.4%) 26 (45.6%) 24 (34.2%)
1 34 (26.8%) 16 (28.1%) 18 (25.7%)
2 42 (33.1%) 15 (26.3%) 27 (38.6%)
(Missing) 5 3 2
M 0.065
0 84 (65.6%) 43 (74.1%) 41 (58.6%)
1 44 (34.4%) 15 (25.9%) 29 (41.4%)
(Missing) 3 2 1
Location 0.020
Right colon 54 (41.2%) 17 (28.3%) 37 (52.1%)
Left colon 50 (38.2%) 27 (45.0%) 23 (32.4%)
Rectum 27 (20.6%) 16 (26.7%) 11 (15.5%)
Emergency treatment 0.000
Immediate resection 78 (59.5%) 48 (80.0%) 30 (42.3%)
DCS 11 (8.4%) 4 (6.7%) 7 (9.9%)
Palliative treatment 42 (32.1%) 8 (13.3%) 34 (47.9%)
Notes: National groups comparison (amean ± standard deviation, median and range). Significant p-values are reported in bold.
Abbreviations: ASA, American Society of Anesthesiologists; DCS, damage control surgery.
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patients should be resected in emergency by the on-call sur-
geons or just stabilized with a damage control procedure and 
then transferred to the colorectal surgeon for the definitive 
treatment. Clearly, there are situations where an emergency 
resection is mandatory, but more often the definitive treat-
ment can be safely postponed, provided that the emergency 
complication is somehow controlled and the general condition 
of the patient is stabilized and possibly improved, following 
the same principles of damage control surgery for trauma.11 
In obstructing CRC, damage-control surgery (DCS) entails 
resolving bowel obstruction with a diversion procedure 
(ileostomy, colostomy, internal bypass, stent). In a perforated 
CRC, DCS may overlap with definitive treatment if an emer-
gency resection of the perforated bowel has to be performed, 
although in patients in poor general condition and without a 
generalized peritonitis it could be sensible to consider only 
percutaneous drainage and proximal diversion. Bleeding 
CRC can be treated at emergency with transfusions and/or 
embolization and/or bleeding control with laser.
Unfortunately, these patients still have a poor prognosis, 
and up to 20% of those operated on for acute obstruction 
due to CRC die within 1 month of the operation.14 Although 
Table 2 Emergency treatment
 Total Umberto I University Hospital Noble’s Hospital
Total 131 60 (45.8%) 71 (54.2%)
Radical resection 89 52 (58.4%) (86.7% within group) 37 (41.6%) (52.1% within group)
Immediate resection 78 48 (61.5%) 30 (38.5%)
Right colectomy 25 (32.1%) 9 (18.8%) 16 (53.3%)
Extended right colectomy 8 (10.3%) 5 (10.4%) 3 (10.0%)
Left colectomy 18 (23.1%) 15 (31.3%) 3 (16.7%)
Extended left colectomy 1 (1.3%) 0 1 (3.3%)
Hartmann’s 10 (12.8%) 7 (14.6%) 3 (10.0%)
Sigmoid colectomy 2 (6.7%) 0 2 (2.6%)
Anterior resection 1 (1.3%) 1 (2.1%) 0
Subtotal colectomy 3 (3.8%) 2 (4.2%) 1 (3.3%)
Total colectomy 10 (12.8%) 9 (18.8%) 1 (3.3%)
p=0.012
Damage control 11 4 (36.4%) 7 (63.6%)
Loop colostomy 9 (81.8%) 2 (50.0%) 7 (100%)
Stent 2 (18.2%) 2 (50.0%) 0
p=0.039
Palliative treatment 42 8 (19.0%) 34 (81.0%)
Terminal colostomy 1 (2.4%) 1 (12.5%) 0
Loop colostomy 7 (16.7%) 2 (25.0%) 5 (14.7%)
Terminal ileostomy 3 (7.1%) 3 (8.8%) 0
Loop ileostomy 8 (19.0%) 2 (25.0%) 6 (17.6%)
Ileotransverse bypass 3 (7.1%) 0 3 (8.8%)
Diagnostic laparoscopy 2 (4.8%) 0 2 (5.9%)
Exploratory laparotomy 3 (7.1%) 1 (12.5%) 2 (5.9%)
Stent 2 (4.8%) 1 (12.5%) 1 (2.9%)
Medical treatment 13 (31.0%) 1 (12.5%) 12 (35.3%)
p=0.305
Colostomya 28 (21.4%) 12 (20.0%) 16 (22.5%)
Ileostomya 27 (20.6%) 16 (26.7%) 11 (15.5%)
No stoma 76 (58.0%) 32 (53.3%) 44 (62.0%)
p=0.289
Laparotomy 89 (67.9%) 51 (85.0%) 38 (53.5%)
Laparoscopy 23 (17.6%) 3 (5.0%) 20 (28.2%)
Conversion lap-open 2 (1.5%) 2 (3.3%) 0
No operation 17 (13.0%) 4 (6.7%) 13 (18.3%)
p=0.000
Emergency surgery <24 h 81 (61.8%) 47 (78.3%) 34 (47.9%)
Delayed surgery >24 h 37 (28.2%) 12 (20%) 25 (35.2%)
Medical treatment 13 (9.9%) 1 (1.7%) 12 (16.9%)
p=0.001
Notes: aTotal number of ostomies, including protective stomas and palliative stomas. P-values of the comparison between the two series (Umberto I vs Noble’s) are reported 
in bold.
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this may partly reflect the more advanced staging of CRC 
patients presenting as emergency, there is evidence that the 
worse outcome may also be due to the fact that these patients 
are usually managed in emergency by nonspecialist general 
surgeons.15
In nonoperable patients, symptom control can be achieved 
with an operative procedure such as a proximal diversion 
or an internal bypass or – better still – a stent, but often the 
disease is so advanced or the patient is so ill that not even a 
palliative procedure can be considered. Almost half of the 
nonresectable patients in this series had such an advanced 
cancer that no palliative procedure was possible.
It is not clear if in advanced cancers a better palliation can 
be achieved with ileostomy or colostomy. The former is usually 
easier and quicker but may not be able to reduce the pressure 
in a distended colon if the ileocecal valve is continent. The lat-
ter can be preferable as it can guarantee a good diversion with 
fewer side effects than ileostomy, but it often requires a degree 
of mobilization. Self-expandable stents are currently a very 
good option for patients with acutely obstructing CRC, either 
Table 3 Distribution of the emergency treatments by factors
 Immediate resection Damage control Palliative treatment p-value
Total 78 (59.5%) 11 (8.4%) 42 (32.1%)
Gender 0.031
M 38 (54.3%) 10 (14.3%) 22 (31.4%)
F 40 (65.6%) 1 (1.6%) 20 (32.8%)
ASA 0.057
1 1 (12.5%) 2 (25.0%) 5 (62.5%)
2 23 (53.5%) 5 (11.6%) 15 (34.9%)
3 36 (65.5%) 4 (7.3%) 15 (27.3%)
4 18 (75.0%) 0 6 (25.0%)
5 0 0 1 (100%)
Presentation 0.043
Obstruction 63 (58.3%) 9 (8.3%) 36 (33.3%)
Perforation 13 (86.7%) 0 2 (13.3%)
Bleeding 2 (25.0%) 2 (25.0%) 4 (50.0%)
Location 0.000
Proximal colon 32 (59.3%) 0 22 (40.7%)
Distal colon 38 (76.0%) 3 (6.0%) 9 (18.0%)
Rectum 8 (29.6%) 8 (29.6%) 11 (40.7%)
Note: Significant p-values are reported in bold.
Abbreviation: ASA, American Society of Anaesthesiologists.
Table 4 Chemotherapy/radiotherapy
 Neoadjuvant 
radiochemotherapy
Adjuvant 
chemotherapy
Palliative 
chemotherapy
No radiotherapy 
or chemotherapy
p-value
Total 6 (4.6%) 42 (32.1%) 16 (12.2%) 67 (51.1%)
Umberto I 1 (1.7%) 23 (38.3%) 3 (5.0%) 33 (55.0%) 0.038
Noble’s 5 (7.0%) 19 (26.8%) 13 (18.3%) 34 (47.9%)
<70 y 5 (9.8%) 21 (41.2%) 8 (15.7%) 17 (33.3%) 0.004
≥70 y 1 (1.3%) 21 (26.3%) 8 (10.0%) 50 (62.5%)
ASA 1 1 (12.5%) 2 (25.0%) 1 (12.5%) 4 (50%) 0.317
ASA 2 3 (7.0%) 14 (32.6%) 9 (20.9%) 17 (39.5%)
ASA 3 2 (3.6%) 21 (38.2%) 5 (9.1%) 27 (49.1%)
ASA 4 0 5 (20.8%) 1 (4.2%) 18 (75.0%)
ASA 5 0 0 0 1 (100%)
Proximal colon 0 17 (31.5%) 10 (18.5%) 27 (50.0%) 0.000
Distal colon 0 20 (40.0%) 4 (8.0%) 26 (52.0%)
Rectum 6 (22.2%) 5 (18.5%) 2 (7.4%) 14 (51.9%)
Immediate resection 0 39 (50.0%) 0 39 (50.0%) 0.000
DCS + resection 5 (45.5%) 3 (27.3%) 0 3 (27.3%)
Palliative treat 1 (2.4%) 0 16 (38.1%) 25 (59.5%)
Laparotomy 3 (2.5%) 37 (31.4%) 16 (13.6%) 62 (52.5%) 0.004
Laparoscopy 3 (23.1%) 5 (38.5%) 0 5 (38.5%)
Note: Significant p-values are reported in bold.
Abbreviations: ASA, American Society of Anesthesiologists; DCS, damage control surgery; y, year.
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as a definitive palliative measure or as a bridge to surgery,16,17 
but in the present series only a few patients had colonic stent-
ing, and so this parameter has not been analyzed.
In patients with an operable disease, both available 
approaches (immediate or delayed resection after DCS) can 
be acceptable. ACPGBI 2007 guidelines16 suggest immediate 
resection and anastomosis for obstructing CRC, mostly on 
the basis of old studies.18 The recently published ACPGBI 
2017 guidelines are less specific and suggest optimization 
of the patient in a high-dependency unit before considering 
emergency surgery or stenting.19 On the contrary, NCCN 
2016 guidelines20 consider both emergency resection or 
elective resection after ileostomy or colostomy as viable 
options. Actually, while some studies failed to demonstrate 
any outcome difference between immediate or delayed resec-
tion,21 there is similarly good evidence claiming that a phased 
strategy is associated with lower mortality and morbidity.7 A 
recent study from Sweden showed that a 2-stage treatment is 
associated with lower morbidity and better nodal clearance in 
comparison to immediate resection.9 However, in this study 
the vast majority of emergency resections were carried out 
by noncolorectal surgeons, whereas subspecialized colorectal 
surgeons usually preferred a staged strategy. On the contrary, 
a recent study from Korea suggested that every patient with 
obstruction due to CRC must have an emergency subtotal 
colectomy, on the basis that staged operations are associated 
with higher mortality and morbidity and longer hospital stay 
in comparison to immediate resections.22
As regards the patients with acute abdomen due to a 
perforated CRC, they almost always need an emergency 
resection, bearing in mind that those cancers are normally 
quite advanced and their long-term prognosis is generally 
poor.23 An extended operation on these patients is associated 
with higher morbidity and mortality;24 so sometimes it may 
be sensible to try a conservative approach. In our series, none 
of the patients with a perforation had a staged resection and 
most of them underwent immediate resection.
This study was planned to try to obtain some further 
scientific evidence that could potentially be useful in the 
decision-making process.
The total number of cases in this analysis is quite high, 
although fortunately the number of CRC cases admitted as 
emergencies is gradually decreasing in Western countries due 
to screening programs and general public awareness. The Isle 
of Man is a closed environment, so the number of patients 
recruited in this study can be considered an exact estimate 
of the real incidence of complicated CRCs (71 cases in 4 
years in a population of 87,000 equates to an incidence of 
about 21 cases/100,000/yr) and matches the data of the UK 
national audit25 and the results published in the literature.6 
On the contrary, it is almost impossible to estimate the real 
incidence of complicated CRC in Italy on the basis of only the 
series from Rome, due to local factors. In fact, the Umberto I 
Emergency Department is only 1 out of 20 EDs in Rome, and 
every one of them has a different workload. For some reason, 
the distribution of surgical emergencies is not uniform within 
the emergency network in the capital city of Rome. Moreover, 
also within the Umberto I University Hospital, a number of 
patients with complicated bowel cancer have not been treated 
by the emergency surgeons and have been transferred under 
other consultants within the same hospital or to other tertiary 
centers, so their data have not been retrieved. The Manx and 
Italian groups match very well for age, gender, TN staging 
of the tumor, and acute complication leading to admission, 
so the pooled analysis of the 2 groups can be considered 
methodologically correct.
However, some evident differences must be emphasized, 
probably due to local policies and attitudes. In fact, whereas 
Manx patients were admitted earlier than the Italian ones 
with respect to the onset of their symptoms, it appears that 
their emergency treatment was somehow delayed once they 
were admitted. In our opinion, this may reflect the particu-
lar geographic configuration of the Isle of Man, where the 
health care services can be easily and quickly accessed by 
any patient, as opposed to the relatively difficult emergency 
access to hospital and specialist review in Rome, but also to 
Table 5 Elective resections after damage control
 Total Umberto I 
University 
Hospital
Noble’s  
Hospital
Hartmann 2 (18.2%) 2 (50.0%) 0
Left colectomy 2 (18.2%) 1 (25.0%) 1 (14.3%)
Abdomino-perineal 
resection
1 (9.1%) 0 1 (9.1%)
Anterior resection 3 (27.3%) 1 (25.0%) 2 (27.3%)
Exenteration 1 (9.1%) 0 1 (9.1%)
Total proctocolectomy 1 (9.1%) 0 1 (9.1%)
Extended right 
colectomy
1 (9.1%) 0 1 (9.1%)
p=0.428
Colostomy 3 (27.3%) 2 (50.0%) 1 (14.3%)
Ileostomy 4 (36.4%) 0 4 (57.1%)
Colostomy + urostomy 1 (9.1%) 0 1 (14.3%)
No stomia 3 (27.3%) 2 (50%) 1 (14.3%)
p=0.155
Laparotomy 7 (63.6%) 4 (100%) 3 (42.9%)
Laparoscopy 4 (36.4%) 0 4 (57.1%)
p=0.058
Note: Significant p-values are reported in bold.
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Table 6 Univariate analysis on resected patients (89 cases)
 Mortality Morbiditya LOSb Ostomy Complementary 
treatment
LN analyzed LN 
adequate 
clearance
R0
Total 12 (13.5%) 24 (27.0%) 16.8±19.8
10 (1–122)
37 (41.6%) 47 (52.8%) 16.4±9.1
14.5 (0–64)
65 (73.0%) 76 (85.4%)
Age (years)
<70 2 (5.7%) 7 (20.0%) 14.4±13.4
10 (4–79)
13 (37.1%) 25 (71.4%) 19.4±11.0
17.5 (5–64)
27 (77.1%) 28 (80.0%)
≥70 10 (18.5%) 17 (31.5%) 18.0±20.8
10.5 
(1–122)
24 (44.4%) 22 (40.7%) 14.4±6.9
13 (0–33)
38 (70.4%) 48 (88.9%)
p 0.084 0.233 0.980c 0.495 0.005 0.030c 0.482 0.246
Presentation
Obstruction 9 (12.5%) 17 (23.6%) 15.4±17.5
10 (1–122)
26 (36.1%) 39 (54.2%) 17.2±9.7
15 (0–64)
53 (73.6%) 63 (87.5%)
Perforatation 2 (15.4%) 4 (30.8%) 19.3±21.6
10 (1–79)
9 (69.2%) 6 (46.2%) 12.7±3.9
14 (5–19)
10 (76.9%) 10 (76.9%)
Bleeding 1 (25.0%) 3 (75.0%) 29.3±18.8
28 (11–50)
2 (50.0%) 2 (50.0%) 12.0±3.6
11 (9–16)
2 (50.0%) 3 (75.0%)
p 0.758 0.075 0.140c 0.078 0.862 0.204c 0.552 0.509
Onset to admission 0.329d 0.351d 0.103d 0.553d 0.706d 0.569d 0.290d 0.125d
Admission to 
treatment
0.549d Coeff 0.007
0.079d
Coeff 0.986
0.000d
0.335d 0.665d 0.751d 0.173d 0.102d
ASA
1 0 0 9.0±7.0
6 (4–17)
2 (66.7%) 3 (100%) 45.5±26.2
45.5 (27-64)
3 (100%) 2 (66.7%)
2 2 (7.1%) 5 (17.9%) 15.9±14.2
9 (6–64)
10 (35.7%) 17 (60.7%) 18.0±7.4
15.5 (2–33)
25 (89.3%) 23 (82.1%)
3 2 (5.0%) 9 (22.5%) 19.0±21.5
11 (1–122)
16 (40.0%) 22 (55.0%) 15.9±7.6
15 (0–34)
28 (70.0%) 37 (92.5%)
4 8 (44.4%) 10 (55.6%) 13.4±17.3
10.5 (1–79)
9 (50.0%) 5 (27.8%) 11.3±4.6
10 (5–19)
9 (50.0%) 14 (77.8%)
p 0.000 0.017 0.357c 0.628 0.046 0.002c 0.019 0.316
Location
Proximal colon 4 (12.5%) 7 (21.9%) 14.5±12.6
9.5 (3–53)
1 (3.1%) 17 (53.1%) 18.8±11.2
15 (5–64)
26 (81.3%) 25 (78.1%)
Distal colon 7 (17.1%) 11 (26.8%) 16.8±21.6
10 (1–122)
21 (51.2%) 20 (48.8%) 15.9±7.7
14 (0–33)
29 (70.7%) 36 (87.8%)
Rectum 1 (6.3%) 6 (37.5%) 20.1±18.9
12 (1–64)
15 (93.8%) 10 (62.5%) 12.4±5.4
12.5 (2–21)
10 (62.5%) 15 (93.8%)
p 0.550 0.516 0.714c 0.000 0.647 0.102c 0.348 0.295
Dukes
B 9 (20.5%) 17 (38.6%) 17.9±17.2
11 (1–79)
21 (47.7%) 18 (40.9%) 14.2±7.6
12.5 (0–34)
26 (59.1%) 39 (88.6%)
C 3 (10.0%) 4 (13.3%) 15.1±21.9
10 (1–122)
11 (36.7%) 20 (66.7%) 20.9±10.4
19 (9–64)
28 (93.3%) 26 (86.7%)
D 0 3 (20.0%) 15.5±13.4
10 (6–53)
5 (33.3%) 9 (60.0%) 14.6±7.7
12 (5–33)
11 (73.3%) 11 (73.3%)
p 0.106 0.044 0.764 0.496 0.077 0.002c 0.005 0.340
Treatment
Immediate 
resection
12 (15.4%) 21 (26.9%) 15.9±18.5
10 (1–122)
27 (34.6%) 39 (50.0%) 16.6±9.4
15 (0–64)
56 (71.8%) 66 (84.6%)
DCS + resection 0 3 (27.3%) 21.3±16.3
17 (4–50)
10 (90.9%) 8 (72.7%) 14.9±5.7
14 (8–27)
9 (81.8%) 10 (90.9%)
p 0.162 0.980 0.160c 0.000 0.157 0.701c 0.483 0.580
(Continued)
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the different set up of the emergency services; Italian ones 
traditionally always being consultant-delivered, with expert 
review and decisions available at any time. Furthermore, UK 
guidelines on the treatment of bowel cancer10 suggest that 
those cases should preferably be dealt with by a specialist 
colorectal surgeon, so patients with CRC presenting with 
a complication are sometimes just stabilized in emergency 
and transferred to a specialist colorectal surgeon as soon 
as possible. If the patient comes in during the weekend, it 
is possible that he or she would not receive any disease-
directed treatment until Monday morning. These differences 
can also explain why in the Italian group the vast major-
ity of patients underwent resection within 24 hours from 
admission, whereas in the Manx group less than half had 
emergency resection. The delay of emergency treatment was 
significantly related to the total length of hospital stay and 
showed a trend toward increased morbidity, thus suggesting 
 Mortality Morbiditya LOSb Ostomy Complementary 
treatment
LN analyzed LN 
adequate 
clearance
R0
Approach
Open 12 (15.8%) 24 (31.6%) 18.0±19.3
11 (1–122)
33 (43.4%) 8 (61.5%) 15.7±7.8
14 (0–34)
53 (69.7%) 64 (84.2%)
Laparoscopy 0 0 8.1±4.6
7 (3–18)
4 (30.8%) 39 (51.3%) 20.0±13.9
19 (8–64)
12 (92.3%) 12 (92.3%)
p 0.123 0.018 0.009 0.392 0.495 0.265 0.090 0.445
Notes: aMorbidity represents the total number of patients who had at least 1 complication during the whole surgical treatment, excluding neoadjuvant or adjuvant treatment. 
bFor patients with 2-stage treatment, LOS is the sum of the 2 admissions. cDifference was estimated with the non-parametric Mann–Whitney U-test as distribution of this 
variable is not normal. dComparison between 2 continuous variables or between an independent continuous variable and a dependent nominal variable has been performed 
with a linear regression. When the 2 variables are somehow correlated, the correlation coefficient is shown, to demonstrate the direction of the correlation. Significant 
p-values are reported in bold.
Abbreviations: ASA, American Society of Anesthesiologists; DCS, damage control surgery; LN, lymph nodes; LOS, length of stay.
Table 6 (Continued)
that the decision-making process should in all circumstances 
be as swift as possible.
Despite presenting early to hospital, Manx patients 
had, more frequently, a metastatic disease at admission. We 
are not sure if this is due to a random effect or to different 
biology and behavior of the tumor. The higher incidence of 
advanced cancer can explain, at least partially, the fact that 
many more patients in the Manx group had only palliative 
treatment, compared to those in the Italian group. However, 
it may also be due to the different attitude toward advanced 
and metastatic disease, where UK guidelines suggest only 
palliative treatment (considering chemotherapy if indicated), 
while Italian surgeons – in the absence of clearly restrictive 
guidelines – are inclined to take a more aggressive approach.
In our series, the choice of treatment was directly related 
to the kind of presentation and location of the tumor, staged 
treatment being more frequent in distal cancers. It is well 
Table 7 Multivariate analysis on resected patients (89 cases)
Dependent variable Independent  
prognostic factors
Correlation coefficient p-value
Mortality ASA 0.156 0.000
Dukes –0.115
Morbidity ASA 0.170 0.000
Dukes –0.136
Laparoscopic resection –0.287
LOS Admission to treatment 0.997 0.000
Onset to admission 0.068
Ostomy Distal cancer 0.458 0.000
Chemoradiotherapy Age >70 –0.307 0.004
LN analyzed ASA –4.953 0.000
Distal cancer –3.164
LN adequate clearance ASA –0.197 0.000
Dukes 0.140
R+ Laparoscopic resection –0.231 0.000
Onset to admission 0.001
Abbreviations: ASA, American Society of Anesthesiologists; LN, lymph nodes; LOS, length of stay.
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known that right colon cancers more frequently present late 
in their course with respect to left colon cancers, and this can 
at least partially explain why palliative treatment was more 
frequent in right colon cancers.
It appears that patients with the highest probability of 
long-term survival were offered a more aggressive approach. 
In fact, younger patients (<70 years old) and those with lower 
ASA scores were more often offered some form of chemo-
radiotherapy and had a better nodal clearance. A similar 
mechanism can explain, in our opinion, why Dukes B patients 
had higher morbidity than Dukes C and D, a more aggressive 
– and hence more prone to complications – approach being 
applied in those with better chances.
As expected, mortality and morbidity were higher in 
elderly patients and in those with multiple comorbidities, 
thus suggesting a more prudent approach in these patients.
Comparison of the 2 branches of treatment did not show 
any significant difference, but patients in the immediate resec-
tion group had higher mortality, and showed a trend toward 
worse node clearance and a lower rate of negative margins 
with respect to delayed resection patients, thus confirming 
findings reported in the literature.9,23 Unfortunately, like 
most of the published articles on this topic, our study lacks 
a long-term follow-up which could be the definitive endpoint 
to establish the best treatment, so we decided to consider 
oncologic outcomes such as good nodal clearance and R0 
resection as reliable surrogates, as they are known to posi-
tively affect survival. Slightly worse oncologic parameters in 
the group of immediate resections can potentially be associ-
ated with poor prognosis, but, even in the presence of this 
discrete trend, our data do not allow us to infer that immediate 
resection is associated with poor long-term survival. This 
issue has not been clarified yet. In fact, while there is good 
evidence clearly demonstrating that emergency presentation 
is independently associated with worse disease-free survival 
and local recurrence,6 some other authors showed that worse 
survival in patients operated on in emergency may not be due 
to the emergency operation itself, but to some other clinical 
factors, including a higher stage at presentation.26
Patients with 2-stage treatment were more likely to have 
a stoma. This apparent paradox can be easily explained by 
the fact that 2-stage treatment entails some form of DCS in 
emergency, and in our series this has almost always been 
a diversion ileostomy or colostomy. It is likely that a more 
extensive use of stents could reduce the odds of having a 
temporary stoma, but only if the concerns related to the use 
of stents as a bridge to surgery are fully resolved.27 However, 
multivariate analysis showed that the odds of having a stoma 
are independently associated only to the distal location of the 
cancer; hence, the higher rate of stoma in staged treatment 
can also be due to the higher rate of distal cancers in the 
same treatment arm.
Patients who had a staged treatment had a higher pos-
sibility of receiving a laparoscopic resection, with all the 
advantages associated with a mini-invasive approach, and 
chemoradiotherapy. Furthermore, they also were likely 
to have the benefit of being operated on by subspecialist 
colorectal surgeons after formal discussion with a multidis-
ciplinary team.
In our experience, laparoscopic resections are associated 
with lower mortality and morbidity, shorter hospital stay, 
better nodal clearance, and a higher rate of R0 resection with 
respect to immediate resection. In particular, laparoscopic 
resection is independently associated with low morbidity 
and R0 resection. Despite the progress and standardiza-
tion of laparoscopic colorectal surgery in elective patients, 
most (>80%) emergency resections are still performed by 
laparotomy.25 One of the reasons for the poor “enthusiasm” 
for the use of laparoscopy in emergency colorectal surgery 
can be the general perception that such an approach is more 
difficult and can be associated with worse results.28 We are 
well aware of the enormous practical difficulties faced when 
trying to implement a program of emergency resective bowel 
surgery off-hours and during weekends, but at least a couple 
of systematic reviews28,29 demonstrated that laparoscopic 
bowel resection in emergency is feasible and does not imply 
an increase in mortality and morbidity. The only remaining 
issue is the longer operative time, which in our opinion is 
not an insurmountable difficulty, considering the widely 
demonstrated advantages of mini-invasive surgery in cancer 
patients and in the acute setting.
This study obviously has the limitations of its retrospec-
tive design, and the 2 main groups having different sizes. 
However, the total number of patients recruited is quite sig-
nificant and allows us to draw some interesting conclusions. 
Merging 2 groups from different social environments has 
not been perceived as a problem, but a good way to reduce 
selection bias.
Conclusion
Our study did not demonstrate a clear superiority of staged 
treatment over immediate resection, or vice versa, in patients 
with resectable CRC presenting as emergency, so both 
approaches can be considered safe and effective. However, 
2-stage treatment is associated with lower mortality and 
a higher rate of laparoscopic resection and adjuvant or 
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neoadjuvant treatment, all positive determinants of a better 
outcome. For this reason, although we agree that the ultimate 
decision should stay with the on-call surgeon and his/her 
discussion with the patient, we feel that a staged treatment 
should always be considered as a viable option until new 
research, and possibly a proper randomized trial, provides 
new evidence.
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